Infectious diseases, Inflammation and Immunity


Clinical Immunology studies the mechanisms of defence, the interaction host-pathogen in infectious diseases, and many illnesses including inflammatory processes, autoimmune diseases, hypersensitivity reactions or immunodeficiency. In most of these processes and in many others, inflammation has been found to be the common element, and is crucial for understanding the basics of this process and its potential prevention or modulation. Moreover, Immunotherapy is changing the way many diseases are treated (e.g. monoclonal antibodies directed to inflammatory cytokines or to tumoral cells), and it is expected that this field will grow in the near future, providing hope tomany patients. Immune response to new nanovaccines and studies related with the biocompatibility of new nanomaterials are areas of special interest in the field of nanotechnology.

Area coordinator:

Prof. África González-Fernández.

Immunologist. BIOCAPS Coordinator.

Leader of  the Immunology Group. Director of Centro de Investigaciones Biomédicas (CINBIO).


Antonio Ocampo Hermida. More info: Internal medicine

Alberto Fernández Villar. More info: Pneumology

Luis Anibarro García. More info: Immunology. CINBIO

José Mª Pego Reigosa. More info: Rheumatology

Francisco Gambón Deza. More info: Immunology. CINBIO

Lines of research:

  • HIV, Hepatitis C, Tuberculosis, Papilloma virus.
  • Lung pathologies.
  • Autoimmune diseases.
  • Immunotherapy.
  • Basic Research on immune memory.
  • Nanotechnology: Immunogenicity and toxicity.

Recent publications:

  • Tamara Lozano-Fernández, Lidia Ballester-Antxordoki,  Nerea Pérez-Temprano, Elena Rojas, David Sanz, Maite Iglesias-Gaspard, Sergio Moya, África González-Fernández,  Mercedes Rey. “Potential impact of metal oxide nanoparticles on the immune system: The role of integrins, L-selectin and the chemokine receptor CXCR4“. Nanomedicine: Nanotechnology, Biology and Medicine.  August 2014; Volume 10, Issue 6: 1301–1310.
  • Sara Vicente, Mercedes Peleteiro, Jose V Gonzalez-Aramundiz, Belén Díaz-Freitas, Susana Martínez-Pulgarín, Jose I Neissa, Jose M Escribano, Alejandro Sanchez, África González-Fernández & Maria J Alonso. “Highly versatile immunostimulating nanocapsules for specific immune potentiation”. Nanomedicine. October 2014; Vol. 9, No. 15: 2273-2289                                   
  • Susana Magadán Mompó and  África González-Fernández. "Human monoclonal antibodies". Chapter 13. Antigen specific monoclonal antibodies from transgenic mice. Methods in Molecular Biology Vol. 1060. Editor: Michael Steinitz. Editorial Humana Press, USA (Springer publishing group) ISBN 978-1-62703-585-9 (2014)
  • Ludmilla Regina de Souza, Luis Alexandre Muehlmann, Mayara Simonelly Costa dos Santos, Rayane Ganassin, Rosana Simón-Vázquez, Graziella Anselmo Joanitti, Ewa Mosiniewicz-Szablewska, Piotr Suchocki, Paulo César Morais, África González-Fernández, Ricardo Bentes Azevedo and Sônia Nair Báo. “PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells”. Journal of Nanobiotechnology. 23 August 2014; 12 (1) 32 (2014)
  • Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, et al. “ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study”. Journal of the International AIDS Society. 02 november 2014; 17(4 Suppl 3): 19814
  • Iribarren  M, Ocampo A, González-Carreró J, Alonso M, Rodríguez M. “Practical considerations for high resolution anoscopy in patients infected with human immunodeficiency virus”. Enfermedades infecciosas y microbiologia clinica. 01 december 2014; Volume 32, Issue 10: 676-680
  • Garcia Federico, Poveda Eva,Pérez-Elías Maria Jesús,Quero José Hernández,Ribas Maria Angels,Martínez-Madrid,Onofre J ,Flores Juan,Crespo, Manel,Gutiérrez Félix ,García-Deltoro Miguel,Imaz Arkaitz ,Ocampo Antonio,Artero Arturo,Blanco Francisco,Bernal Enrique,Pasquau Juan,Mínguez-Gallego Carlos,Pérez Núria,Aiestarán Aintzane,Paredes Roger. “Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study”. Journal of the International AIDS Society. 02 november 2014; Vol. 17(4 Suppl 3): 19520
  • Núñez MJ, Fachal C, Durán D, Figueroa RM, Sopeña B, García JC, Anibarro L. "IgG4-related disease and isolated thoracic aortic aneurysm”. European Journal of Vascular Medicine. September 2014; 43:385-389
  • Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM; EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology). “ Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences”. Revista: Medicine (Baltimore) 2015 Jan; 94(1):e267.
  •  Pego-Reigosa JM, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, del Campo V, et al.; on behalf of the RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER). “Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus”.  Lupus 2014 Dec 15. pii: 0961203314563818.
  •  Saketkoo LA, Mittoo S, Frankel S, et al; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. “Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases”.  J Rheumatol 2014; 41:792-8.
  • Saketkoo LA, Mittoo S, Huscher D, et al.; CTD-ILD Special Interest Group. “Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials”. Thorax 2014; 69:428-36.
  • Silva-Fernández L, Loza E, Martínez-Taboada VM, Blanco R, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S; Systemic Autoimmune Diseases Study Group of the Spanish Society for Rheumatology (EAS-SER). “Biological therapy for systemic vasculitis: A systematic review”. Semin Arthritis Rheum 2014; 43:542-57.
  • Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Olivé Marqués A, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández  S. “Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review”. Semin Arthritis Rheum  2014; 44:175-85.



Tuesday, July 28, 2015
The Infectious Diseases section of BIOCAPS adds this award to the appointment of África González as President of the Spanish Immunology Society
Monday, June 22, 2015
The Ebola crisis and recent progress in the field of infectious diseases were the subject of the fifteenth BIOCAPS seminar
Wednesday, May 27, 2015
Free registration is open for the final two scientific seminars organised by IBI before summer